These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of tolerance using porcine factor VIII. Hay CR, Laurian Y. Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473 [No Abstract] [Full Text] [Related]
6. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CR. Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192 [Abstract] [Full Text] [Related]
9. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects. Hay CR, Lozier JN, Lee CA, Lafan M, Tradati H, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A. Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768 [No Abstract] [Full Text] [Related]
11. Immunogenicity and immune tolerance coagulation Factors VIII and IX. Rup B. Dev Biol (Basel); 2003 Apr; 112():55-9. PubMed ID: 12762504 [Abstract] [Full Text] [Related]
12. Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group. Abildgaard CF. Semin Hematol; 1991 Apr; 28(2 Suppl 1):44. PubMed ID: 1908127 [No Abstract] [Full Text] [Related]
17. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII. Verroust F, Allain JP. Thromb Haemost; 1982 Oct 29; 48(2):238. PubMed ID: 6817447 [No Abstract] [Full Text] [Related]
19. Acquired hemophilia. Bouvry P, Recloux P. Haematologica; 1994 Oct 29; 79(6):550-6. PubMed ID: 7896216 [Abstract] [Full Text] [Related]
20. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Kessler CM, Ludlam CA. Semin Hematol; 1993 Apr 29; 30(2 Suppl 1):22-7. PubMed ID: 8480193 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]